baber/WOPTO huggingface dataset:
Patent FI-900426-A0 (FI)
Inventor: NORDLUND KAI
IPC: B65D81/02
Filed: 1990-01-26
Abstract: PCT No. PCT/FI91/00022 Sec. 371 Date Sep. 27, 1991 Sec. 102(e) Date Sep. 27, 1991 PCT Filed Jan. 23, 1991 PCT Pub. No. WO91/11373 PCT Pub. Date Aug. 8, 1991.A package blank is provided including a wrapping material and a substantially deformable inner material. The wrapping material consists of a resilient film having a sealed inner space. The inner material consists of particles accommodated within the sealed inner space. At least one article is surrounded by the package blank. During a package forming process, pressure is reduced within the inner space and the article is surrounded by the blank. The pressure reduction causes the wrapping material to tightly encircle the article, the inner material to be stiffened, and the particles to be substantially immobilized relative to each other. A stiffening plate included on a surface of the wrapping material is adapted to receive a piercing device during the package forming process. The piercing device penetrates the wrapping material and the stiffening plate and establishes a communication between the sealed inner space and a vacuum creating mechanism. A sealing member closes the communication upon removal of the piercing device.
Patent FI-905785-A0 (FI)
Inventor: HECKLER MARK
IPC: B66B13/26
Filed: 1990-11-23
Abstract: By means of this method and the arrangement, in the case of an automatic door, especially in the case of lifts with a controlled door drive which moves doors of a cabin door by means of a motor with a reduction gear and a mechanical drive, and moves doors of a shaft door via mechanical coupling elements, protection against being caught, responding up to the last few mm of a door closing movement with constant force levels, is provided. In this case, this is done by a control error dV being continuously compared during the door closing movement with a maximum permissible control error dVmax produced by a nominal value sensor (3.5) and, if this maximum control error is exceeded, the door is stopped with subsequent reversing. The response levels for an external disturbing force (3.9) are kept constant by a calibration trip computer (3.11) determining values for mass compensation (3.12) and values for friction compensation (3.13) during periodic calibration trips and supplying these values as a compensation value Vk to a second comparator (3.2). In consequence, the magnitude of an external disturbing force (3.9) is also known, or can be measured precisely, with a defined gain of the controller (3.8) and a known torque characteristic of the DC motor (2.1), which creates the precondition for safe protection against being caught. 
<IMAGE>
Patent FI-911961-A0 (FI)
Inventor: BROOKE GERALD STEPHEN
IPC: C12P21/02
Filed: 1991-04-23
Abstract: The present invention provides novel analogs of growth hormone releasing factor (GRF). Chemically modified versions of these molecules are also provided as are DNA compounds encoding GRF analogs. Some of the polypeptide compounds can be obtained in large yields by production of the compounds in E. coli. The invention also provides pharmaceutical compositions and methods for the inducement of growth hormone release.
Patent FI-920154-A0 (FI)
Inventor: HAMM DONALD J
IPC: C12P21/06
Filed: 1992-01-14
Abstract: A process for the production of hydrolyzed vegetable proteins containing no detectable level of monocholorodihydroxypropanol and substantial flavor enhancement characteristics by using enzymatic hydrolysis of the protein followed by mild acid hydrolysis with gaseous hydrochloric acid and the product therefrom.
Patent FI-920428-A0 (FI)
Inventor: LEANDER KURT
IPC: A61K31/34
Filed: 1992-01-30
Abstract: The invention refers to new pharmaceutical preparations for the treatment of psoriasis and condyloma acuminata, and containing podophyllotoxin in combination with a liquid triglyceride.
Patent FI-922717-A0 (FI)
Inventor: SELMER JOERGEN
IPC: F02B3/06
Filed: 1992-06-11
Abstract: PCT No. PCT/SE90/00823 Sec. 371 Date Jun. 15, 1992 Sec. 102(e) Date Jun. 15, 1992 PCT Filed Dec. 12, 1990 PCT Pub. No. WO91/08946 PCT Pub. Date Jun. 27, 1991.A method and a device for power transmission from a motor having a supercharging assembly, particularly a supercharged diesel-engine (7), to a gear (3) with a surface water driving propeller mechanism (4) mounted in a boat of the planing variety and preferably with a large propeller with a large pitch. A turbine coupling (10), which can be filled to a variable extent, is mounted between the supercharged motor (7) and the gear (3). The motor is designed to drive the pump portion (15) of the turbine coupling (10), and the turbine portion (17) of the turbine coupling (10) is connected to the input shaft (6) of the gear (3). The turbine coupling (10), when the boat is started, is emptied completely or partially, in such a way that it is at least partially disconnected from the gear. The motor is then accelerated to such a speed that the supercharging assembly of the motor (7) is connected. The turbine coupling is subsequently quickly filled with hydraulic medium, so that the propeller mechanism (4) is influenced by the substantially maximum output of the motor, caused by the supercharging assembly. When the boat has reached its planing speed, the motor speed in the desired way is reduced and/or the extent of filling of the turbine coupling is reduced, but no to a lower speed than that the boat will be propelled with a speed which is somewhat larger than the planing limiting speed. The invention also relates to the use of a turbine coupling in planing boats having gears of the above-described variety.
Patent FI-924937-A0 (FI)
Inventor: MURAMATSU RYO
IPC: A61K38/00
Filed: 1992-10-30
Abstract: A hirudin analogue having high antithrombin activity and platelet aggregation resistance, represented by formula Phe-Glu-A-Ile-Pro-B-Tyr(R)-Tyr(R) and having a tyrosine residue with its hydroxyl group optionally sulfated. In the said formula, A represents Glu or Pro; B represents Glu, Tyr(R), Glu-Asp or Glu-Tyr(R); and (R) represents the hydroxyl group of a tyrosine residue or the sulfate thereof (-O-SO3H). A process for producing a hirudin analogue by sulfating the hydroxyl group of the tyrosine residue. An anticoagulant containing the hirudin analogue (I) as the active ingredient.
Patent FI-925515-A0 (FI)
Inventor: REICHERT PAUL
IPC: C07K14/56
Filed: 1992-12-04
Abstract: A method for making crystals of zinc interferon alpha-2, and the use thereof in depot formulations, are disclosed.
Patent FI-934329-A0 (FI)
Inventor: BUISMAN CEES JAN NICO
IPC: C01B17/24
Filed: 1993-10-01
Abstract: PCT No. PCT/NL92/00064 Sec. 371 Date Dec. 6, 1993 Sec. 102(e) Date Dec. 6, 1993 PCT Filed Apr. 3, 1992 PCT Pub. No. WO92/17410 PCT Pub. Date Oct. 15, 1992.The invention provides a method for removing sulphur compounds from water by anaerobic reduction of the sulphur compounds to sulphide, followed by a partial oxidation of the sulphide to elementary sulphur. The anaerobic reduction is carried out at elevated temperature, either continuously at a temperature of 45 DEG -70 DEG  C., or periodically at a temperature of 55 DEG -100 DEG  C. If the reduction is carried out periodically, a single rise in temperature for a few hours to several days over a period of 3-6 months can suffice. The method is particularly applicable to the removal of sulphate, sulphite and thiosulphate.
Patent FI-962979-A0 (FI)
Inventor: ARVINTE TUDOR
IPC: A61K47/12
Filed: 1996-07-26
Abstract: The present invention provides a freeze dried pharmaceutical composition comprising hirudin, potassium phosphate and a sugar.
Patent FI-965156-A0 (FI)
Inventor: MACPHERSON LAWRENCE JOSEPH
IPC: C07D223/10
Filed: 1996-12-20
Abstract: The invention relates to a method of inhibiting metalloellastase activity, of inhibiting the degradation of elastin, or of treating macrophage metalloelastase dependent conditions in mammals which comprises administering to a mammal in need thereof an effective macrophage metalloelastase inhibiting amount of a compound of formula I    <IMAGE>  (I)  wherein Ar, R, R1 and R2 have meanings as defined, or of a pharmaceutically acceptable prodrug derivative thereof, or of a pharmaceutically acceptable salt thereof, or of pharmaceutical compositions comprising a said compound.
Patent FI-971472-A0 (FI)
Inventor: ERIKSSON STAFFAN
IPC: H02G3/12
Filed: 1997-04-09
Abstract: A mounting frame (100) to be fixed in a front opening of an electrical service-provider (4) of the type having a front comprising mutually facing flanges on at least two opposite sides of the opening which frame is intended for mounting a desired functional unit on or in the service-provider. The frame (100) is designed so that it could be fixed in said front opening in at least two positions which differ from each other by 90 DEG  in rotational direction in the plane of the frame.
Patent AP-9300577-A0 (AP)
Title: Cyanophenyl-pyrazolines.
Inventor: DR VAN ALMSICK ANDREAS
IPC: C07D231/06
Filed: 1993-10-04
Abstract: Pyrazoline derivatives of general formula 1 in which r1 and r2 are phenyl, optionally substituted by one or more of the same or different groups selected from cyano, halogen,nitro,c1-6-alkyl, c1-6-alkoxy, halo-c1-6-alkyl or halo-c1-6alkoxy, in which at least one of the phenyl groups is substituted by cyano; r3 is phenyl or cyclohexyl, each of which is optionally substituted by one or more of the same or different groups selected from halogen, nitro,cyano,c1-6-alkyl,c1-6-alkoxy, c1-6-alkoxy, halo-c1-6-alkyl, halo-c1-6-alkoxy, c1-6-alkylsulfonyl, haloc1-6-alkylsulfonyl or c1-6-alkyoxycarbonyl; and r4 is hydrogen, c1-6-alkyl, halo-c1-6-alkyl, c1-6-acyl,, c1-6-alkoxycarbonyl or halo-c1-6-acyl, c1-6-alkoxycarbonyl or halo-c1-6-alkoxycarbonyl, have insecticidal and acaricidal activity.
Patent IL-61272-A0 (IL)
Title: Substituted ureas, their manufacture and their use as herbicides
IPC: C07D237/14
Filed: 1980-10-14
Abstract: 1. A substituted urea of the formula I  see diagramm : EP0027965,P26,F1  where R**1 denotes substituted phenyl of one of the formulae  see diagramm : EP0027965,P26,F2   see diagramm : EP0027965,P26,F3  or  see diagramm : EP0027965,P26,F4  R', R" and R'" being identical or different and each denoting hydrogen, halogen, nitro, lower alkyl, halo-lower alkyl, cyano, lower alkoxy, halo-lower alkoxy, lower alkylmercapto, lower alkylsulfinyl or lower alkylsulfonyl, or R**1 denotes substituted or unsubstituted heteroaryl, R**2 denotes hydrogen, lower alkyl, lower alkoxy, lower alkenyl, lower alkynyl or cycloalkyl, R**3 denotes hydrogen or lower alkyl, R**2 and R**3 together also being able to denote oligomethylene or oxaoligomethylene, and X denotes hydrogen, halogen, nitro, lower alkyl, halo-lower alkyl, lower alkoxy, halo-lower alkoxy, or cyano, but does not denote nitro if R**2 and/or R**3 are lower alkyl.
Patent IL-66853-A0 (IL)
Title: Pharmaceutical compositions comprising levallorphan derivatives
IPC: A61K31/47
Filed: 1982-09-22
Abstract: The present invention relates to a pharmaceutical composition having a peripheral antagonistic action with respect to opiates containing, as active ingredient, a haloallylate of levallorphan of formula: <IMAGE>   where X is chlorine, bromine or iodine, mixed with a pharmaceutical excipient.
Patent IL-67447-A0 (IL)
Title: Microorganisms of the genus pseudomonas and process for degrading compounds which contain methyl groups in aqueous solutions
IPC: C12N1/32
Filed: 1982-12-09
Abstract: The present invention relates to novel facultative methylotrophic microorganisms of the genus Pseudomonas, or of a genus Pseudomonas-type genus, to protein-containing biomass, and to a process for the microbiological purification of aqueous solutions, e.g. wastewater solutions, which contain methanol, ethanol, acetate, glucose, alkylammonium compounds, e.g., trimethylethylammonium chloride, or alkylamine oxides, e.g. trimethylamine oxide, as pollutants.
Patent IL-68191-A0 (IL)
Title: Substituted n,n-dimethyl-o-pyrimidin-4-yl carbamates,their preparation and their use as pesticides
IPC: C07D239/70
Filed: 1983-03-22
Abstract: Substituted N,N-dimethyl O-pyrimidin-4-yl carbamates of the formula <IMAGE>   in which R is alkyl, R1 is hydrogen or optionally substituted alkyl, alkoxy, alkylthio, alkylsulphinyl or alkylsulphonyl, R2 is hydrogen or optionally substituted alkyl, or R1 and R2 together form an optionally substituted alkylene, A is alkylene having more than 1 carbon atom, and n is 0, 1 or 2, which possess insecticidal activity.
Patent IL-79953-A0 (IL)
Title: Isolation of unreduced oligosaccharides
IPC: A61K38/55
Filed: 1986-09-05
Abstract: A preparative scale method for the isolation of unreduced oligosaccharides of glycoproteins and glycohormones having a N-linked oligosaccharide structure is disclosed. The method employs hydrazin­olysis of the glycoprotein or glycohormone under reaction conditions to cause cleavage at the N-linked sites, producing a mixture having as a major component a de-N-acetylated hydrazone derivative of the oligo­saccharides, followed by N-acylation of the hydrazone derivative, acid-catalysis of the hydrazone derivative to produce unreduced oligosaccharides, and subjecting the resulting unreduced oligosaccharides to cellulose column chromatography to remove contaminants and to recover the unreduced oligosaccharides.
Patent IL-84536-A0 (IL)
Title: Insect-resistant tomato plants
IPC: A01H5/00
Filed: 1987-11-19
Abstract: A method for producing genetically transformed tomato plants exhibiting toxicity to Lepidopteran larvae is disclosed. In another aspect, the present invention embraces chimeric plant genes, genetically transformed tomato cells and differentiated tomato plants which exhibit toxicity to Lepidopteran larvae.
Patent IL-92950-A0 (IL)
Title: Piperidine derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61P9/00
Filed: 1990-01-02
Abstract: The invention relates to piperidines represented by the formula: 
<IMAGE>
 in which X is a 4-fluorobenzoyl, 2-(4-fluorophenyl)-1,3-dioxolan-2-yl or 6-fluoro-1,2-benzisoxazol-3-yl group, Y is a hydrogen atom or a hydroxyl group, m is an integer between 0 and 4 inclusive, n is 0 or 1, Q is a nitrogen atom or a methine group; when Q is a nitrogen atom, R is a cyano group or a carbamoyl group; when Q is a methine group, R is a nitro group; R<1> and R<2> can be identical or different and are hydrogen, a lower alkyl radical, a phenyl radical, a 2,2,2-trifluoroethyl group or a 2-[4-(4-fluorobenzoyl)-1-piperidyl]ethyl group; or the structural unit NR<1>R<2> is a piperidino radical or a 4-(4-fluorobenzoyl)-1-piperidyl group. 
<??>Use of these compounds as antihypertensive pharmaceuticals.
Patent IL-99674-A0 (IL)
Title: Process for the preparation of acylaminomethane-phosphonic acids
IPC: C07F9/38
Filed: 1991-10-08
Abstract: Acylaminomethanephosphonic acids are useful intermediates for the preparation of the herbicide N-phosphonemethylglycine and its salts. According to the invention, acylaminomethanephosphonic acids of the formula (I) R1-CO-NHCH2P(=O) (OH)2 (I) in which R1 is H, C1-C6-alkyl, benzyl or optionally substituted phenyl, can be prepared in a process which can be employed industrially, which comprises the reaction of the compound of the formula R1-CO-NH-CH2OH with P2O3 and then hydrolysis with water.
Patent FI-20040974-A0 (FI)
IPC: B62J99/00
Filed: 2004-07-12
Abstract: The invention relates to a memory card for a mobile telephone, and a data-transfer method. The memory card according to the invention includes a receiver, which is able to receive information from at least one peripheral device of a wristop computer, or from a wristop computer.
Patent IL-112055-A0 (IL)
Title: Guar as drift control agent
IPC: A01N25/00
Filed: 1994-12-19
Abstract: The drifting of aerial spraying or scattering of aqueous compositions is controlled by using suitable nonviscoelastic quantities of guar gum or else of one or more guar gum derivatives or of their combinations. Applications to the preparation of aqueous formulations for spraying, especially in the field of agricultural chemicals.
Patent IL-113973-A0 (IL)
Title: Manufacture of paper
IPC: D21H17/67
Filed: 1995-06-01
Abstract: Paper strengthened by starch, typically in amounts of 3 to 15% dry weight, is made by flocculating a cellulosic suspension using a polymeric retention aid which can be dissolved cationic starch but is preferably a synthetic polymer having IV above 4dl/g, shearing the resultant flocculated suspension and reflocculating it by adding bentonite or other microparticulate anionic material, draining the flocculated or reflocculated suspension and drying the resultant wet sheet, wherein insoluble particles of starch are added to the suspension as a slurry of substantially freely dispersed particles in part or all of the aqueous solution of the polymeric retention aid.
Patent IL-114449-A0 (IL)
Title: Multiple unit tableted dosage form
IPC: A61K31/435
Filed: 1995-07-04
Abstract: A new pharmaceutical multiple unit tableted dosage form containing as active substance an acid labile H<+>K<+>-ATPase inhibitor or an alkaline salt thereof or one of its single enantiomers or an alkaline salt thereof, a method for the manufacture of such a formulation, and the use of such a formulation in medicine.
Patent IL-114971-A0 (IL)
Title: Universal masterbatch
IPC: C08K3/04
Filed: 1995-08-17
Abstract: A universal masterbatch composition for adding fillers and particularly pigment to polymers, having up to 85%, by weight, of at least one filler being carbon black, titanium dioxide or ultramarine blue, up to 25%, by weight, of at least one viscosity modifier being ethylene bis stearamide, polybutylene or hot melt acrylate copolymers and a remainder quantity of a styrene butadiene block copolymer. The composition preferably further includes up to 5%, by weight, of at least one processing aid in the form of metallic stearates, stearic acid, organic stearates or fluoroelastomer and up to 2%, by weight, of at least one antioxidant.
Patent IL-133631-A0 (IL)
Title: Intracardiac blood pump
IPC: A61M60/857
Filed: 1999-04-24
Abstract: The intracardiac blood pump (10) comprises a drive section (11) and a pump section (12). A flexible pump hose (14) is connected to the pump section (12). To lay the pump hose (14) from the right atrium (21) to the pulmonary artery (26) the distal end of the pump hose (14) comprises a balloon (35) which acts as guide element in the blood flow and is entrained by the natural blood flow. This facilitates placing of the blood pump in the heart.
Patent IL-140437-A0 (IL)
Title: Pharmaceutical compositions comprising 2-quinolines
IPC: C07D401/06
Filed: 1999-07-13
Abstract: The invention concerns a pharmaceutical composition having an activity on the proliferation of clonogenic cells in tumours and comprising an efficient amount of a compound selected among the compounds of formulae (I) and (Ia) wherein: X, R1, R2, R3, R4, R5, R6 are as defined in claim 1.
Patent IL-146217-A0 (IL)
Title: Mutual crosstalk elimination in medical systems
IPC: G01V3/10
Filed: 2001-10-29
Abstract: Apparatus for generating magnetic fields includes a plurality of radiator coils. Driver circuitry drives the coils so as to generate magnetic fields at a plurality of driving frequencies. Each of the coils is driven by a respective current that comprises a basic current at a respective one of the driving frequencies and cancellation currents at one or more of the other driving frequencies, so that each of the radiator coils generates a field substantially only at the respective driving frequency. <IMAGE>
Patent IL-155349-A0 (IL)
Title: Analyte concentration determination devices and methods of using the same
IPC: A61B5/151
Filed: 2003-04-10
Abstract: Devices and methods for analyte concentration determination are provided. The subject devices have a housing having an aperture, a lancing element having a lancet held therein disposed within the housing, means for activating the lancing element to displace the lancet to provide an incision in an area of skin to provide physiological sample, and means for determining whether a sufficient amount of the physiological sample is present at the surface of the skin. The subject methods include lancing an area of skin to provide physiological sample at the surface of the area of skin, illuminating the physiological sample present at the surface of skin, detecting light reflected from the physiological sample, and determining whether the physiological sample is present in an amount sufficient for analyte concentration determination based upon the detected light. The subject invention also includes kits for use in practicing the subject methods.
Patent IL-157159-A0 (IL)
Title: Magnetic and electrostatic confinement of plasma in a field reversed configuration
IPC: G21B1/00
Filed: 2002-02-01
Abstract: A system and method for containing plasma and forming a Field Reversed Configuration (FRC) magnetic topology are described in which plasma ions are contained magnetically in stable, non-adiabatic orbits in the FRC. Further, the electrons are contained electrostatically in a deep energy well, created by tuning an externally applied magnetic field. The simultaneous electrostatic confinement of electrons and magnetic confinement of ions avoids anomalous transport and facilitates classical containment of both electrons and ions. In this configuration, ions and electrons may have adequate density and temperature so that upon collisions they are fused together by nuclear force, thus releasing fusion energy. Moreover, the fusion fuel plasmas that can be used with the present confinement system and method are not limited to neutronic fuels only, but also advantageously include advanced fuels.
Patent IL-212777-A0 (IL)
Title: Baloon catheter
IPC: A61L29/16
Filed: 2011-05-09
Abstract: A drug delivering medicinal device (A) for selective therapy of particular diseased tissue segments or organ parts comprises a device to be contacted (for at least a short period) under pressure with the diseased region, carrying on the surface a lipophilic, water-insoluble drug (I) which bonds with tissue components, such that (I) is released immediately on contact with tissue. An independent claim is included for the preparation of (A).
Patent RO-127733-A0 (RO)
Title: Product of natural origin for ophthalmic treatment and process for preparing the same
Inventor: DASS MOHAMMED MARWAN
IPC: A61K36/06
Filed: 2011-01-13
Abstract: The invention relates to an ophthalmic treatment which is active in ophthalmic diseases of cornea and in glaucoma. According to the invention, the product is prepared from brown desert truffles of fungi of Terfezia genus, by extraction in demineralized water in a ratio of 2...3:1 g/v, at a temperature of 4°C, the extract being separated by filtration on an adjunct layer (celite) or by centrifugation, being then purified by ultrafiltration on membranes with an exclusion limit of 10 kDa, the resulting permeate being concentrated under vacuum at 1:6...1:9 v/v and finally there being added benzalkonium chloride 0.01% g/v and sodium chloride 0.6% g/v to obtain a product packaged in sterile flasks of 5...10 ml.
Patent RO-133528-A0 (RO)
Title: Scripor alphabet - the alphabet of colours for visually impaired people
Inventor: SCRIPOR TUDOR PAUL
IPC: G09B21/00
Filed: 2018-12-21
Abstract: The invention relates to an alphabet intended to enable colour recognition by visually impaired persons, either blind or with serious sight deficiencies. According to the invention, the alphabet comprises matrices consisting of ten tactile-graphic dots, nine of which are arranged in three columns of three dots each, plus an omnipresent orientation dot placed above the middle column, the matrices defining twenty six tactile-graphic signs, of which eight represent basic colours, two are non-colours and sixteen are colour shades.